Literature DB >> 1474363

Hypercalcaemia in Addison's disease: calciotropic hormone profile and bone histology.

A Montoli1, G Colussi, L Minetti.   

Abstract

Three cases of hypercalcaemia secondary to acute adrenocortical insufficiency are described; all the patients had moderate to severe renal impairment, one being on chronic dialysis treatment with no residual diuresis. Parathyroid hormone (PTH) and 1,25 dihydroxyvitamin D [1,25(OH)2D] were low, indicating a suppressed PTH-vitamin D axis. In the two patients with partial renal impairment, urine Ca excretion was increased, indicating increased load of the cation into the extracellular fluid (ECF), most probably from bone. Saline infusion, to correct any ECF depletion and to increase urine Ca excretion, could not fully correct the hypercalcaemia. Complete correction of plasma Ca levels was observed shortly after the institution of hormonal substitutive therapy. Despite the evidence of increased Ca mobilization from bone, bone biopsies in two patients did not show any signs of cell-mediated bone resorption; instead, bone cell activity appeared to be suppressed. Thus, glucocorticoid deficiency appears to induce Ca mobilization from bone stores by mechanism(s) unrelated to bone remodelling processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474363     DOI: 10.1111/j.1365-2796.1992.tb00636.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

1.  Adrenal insufficiency secondary to inappropriate oral administration of topical exogenous steroids presenting with hypercalcaemia.

Authors:  Rahila Sarwar Bhatti; Michael D Flynn
Journal:  BMJ Case Rep       Date:  2012-06-21

Review 2.  Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.

Authors:  Barbara Altieri; Giovanna Muscogiuri; Luigi Barrea; Chantal Mathieu; Carla V Vallone; Luca Mascitelli; Giorgia Bizzaro; Vincenzo M Altieri; Giacomo Tirabassi; Giancarlo Balercia; Silvia Savastano; Nicola Bizzaro; Cristina L Ronchi; Annamaria Colao; Alfredo Pontecorvi; Silvia Della Casa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 3.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

Review 4.  Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?

Authors:  Claudia Fofi; Barbara Maresca; Silvia Altieri; Paolo Menè; Francescaromana Festuccia
Journal:  Intern Emerg Med       Date:  2019-10-17       Impact factor: 3.397

5.  Elevated bone resorption markers in a patient with hypercalcemia associated with post-partum thyrotoxicosis and hypoadrenocorticism due to pituitary failure.

Authors:  M Fujikawa; K Kamihira; K Sato; K Okamura; S Kidota; M Lida
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

6.  Cushing's syndrome patient who exhibited congestive heart failure.

Authors:  L Petramala; P Battisti; G Lauri; L Palleschi; D Cotesta; M Iorio; G De Toma; S Sciomer; C Letizia
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

7.  Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies.

Authors:  Sreeram V Ramagopalan; Raph Goldacre; Giulio Disanto; Gavin Giovannoni; Michael J Goldacre
Journal:  BMC Med       Date:  2013-07-25       Impact factor: 8.775

8.  Hypercalcemia in a patient with autoimmune polyglandular syndrome.

Authors:  Svetlana Katsnelson; Jessica Cella; Heesuk Suh; Marina M Charitou
Journal:  Clin Pract       Date:  2012-04-04

9.  A case of acute psychosis in an adolescent male.

Authors:  Ghufran Babar; Ramin Alemzadeh
Journal:  Case Rep Endocrinol       Date:  2014-03-30

10.  Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate.

Authors:  Erina Yuasa-Shibasaki; Sumiyasu Ishii; Shunichi Matsumoto; Takuya Tomaru; Kazuhiko Horiguchi; Aya Osaki; Atsushi Ozawa; Nobuyuki Shibusawa; Tetsurou Satoh; Masanobu Yamada
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.